glucuronic acid has been researched along with Colitis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Allarà, M; De Petrocellis, L; Di Marzo, V; Izzo, AA; Manzo, E; Pagano, E; Petrosino, S; Schiano Moriello, A; Tinto, F; Verde, R | 1 |
| Gjurovski, I; Ivanovska, TP; Mladenovska, K; Pavlova, MJ; Petrushevska-Tozi, L; Ristoski, T; Zhivikj, Z | 1 |
| Brown, K; Grigoryan, A; Inglis, GD; Korber, DR; Nickerson, MT; Uwiera, RRE; Varankovich, N | 1 |
| Abballe, V; Adejo, I; Ahmadu, SK; Alfeeli, MA; Ali, S; Anderson, CD; Ayana, GT; Babb, J; Bae, HJ; Bai, X; Ben Salem, M; Ben Younes, A; Bhunia, AK; Bjelovučić, R; Bostock, E; Buscombe, JR; Chan, KH; Chan, PS; Chanrion, O; Chen, C; Chen, J; Chen, X; Cheng, J; Cho, ML; Choi, JW; Choochuay, S; Courie, R; Crawford, KM; Cui, Z; Dagher, I; Darelius, E; Drolia, R; Du, F; El Abed, H; Elgazzar, AH; Fang, Z; Fenchel, M; Feng, Y; Franceschi, AM; Fried, D; Fried, NM; Friedman, KP; Gaillard, M; Garry, M; Gonzalez Hernandez, JL; Guo, J; Guo, W; Han, C; Han, Y; Han, YY; Hansel, B; Hawrelak, JA; Hermansyah, H; Holdship, P; Hong, YC; Hu, Y; Huang, S; Ikeda, M; Isarankura-Na-Ayudhya, C; Isarankura-Na-Ayudhya, P; Jackson, K; Jala, P; James, ML; Jarraya, R; Jiang, R; Jianping, C; Jing, F; Jung, KA; Kim, DS; Kim, EK; Kim, S; Kirkby, K; Kittner, SJ; Köhn, C; Kwok, SK; Kwon, JE; Lainas, P; Langefeld, CD; Lee, SH; Lena, UK; Li, G; Li, J; Li, S; Li, T; Li, Z; Liang, M; Liepe, K; Lim, YH; Lischer, K; Liu, B; Liu, D; Liu, F; Liu, LY; Liu, X; Liu, ZZ; Liwen, Z; Lu, W; Luo, X; Lyu, N; Ma, T; Maneeboon, T; Marini, S; Mizoguchi, M; Moomaw, CJ; Moon, YM; Moriya, K; Nantasenamat, C; Naveau, S; Nelson, A; Neubert, T; Nowosinska, E; Oginni, A; Okazaki, M; Okugawa, S; Okwesa, N; Oshida, Y; Pannengpetch, S; Par, M; Park, MJ; Park, S; Park, SH; Peng, Z; Phakam, J; Porteous, N; Prachayasittikul, V; Pratami, DK; Price, D; Prskalo, K; Qiu, Z; Raad, RA; Rickaby, REM; Rosand, J; Routy, B; Routy, JP; Ryu, JG; Sahlan, M; Saito, R; Sallée, JB; Sarikaya, A; Sarikaya, I; Schaduangrat, N; Sehgal, SK; Shekerau, H; Shepherd, TM; Shi, W; Sidhu, JS; Singh, AK; Skendrović, H; Snow, JT; Song, X; Spanović, N; Sun, Y; Tansakul, N; Tarle, Z; Tatsuno, K; Taylor, B; Tenguria, S; Testai, FD; Thippakorn, C; Tranchart, H; Turnipseed, B; Vahle, T; Valadez, GH; Wang, CL; Wang, X; Wang, Y; Watson, P; Wen, J; Wijanarko, A; Woo, D; Wu, F; Wu, Y; Xia, Y; Xiao, Y; Xie, J; Xiu, K; Xu, HA; Xu, P; Yanbo, D; Yang, EJ; Yang, W; Yang, Y; Yun, Z; Zeng, XC; Zhan, Y; Zhang, L; Zhang, M; Zhang, Q; Zhao, C; Zhao, L; Zhao, X; Zheng, Y; Zhou, H; Zhou, M; Zhu, B; Zhu, J; Zhu, T; Zhu, X; Zou, S | 1 |
| Bae, J; Hasan, N; Im, E; Jung, Y; Kim, J; Kim, W; Lee, J; Naeem, M; Oshi, MA; Yoo, JW | 1 |
| Itoh, T; Nasu, R; Nishida, R; Yamamoto, A | 1 |
| Ayyadurai, S; Baker, MT; Charania, MA; Gewirtz, AT; Laroui, H; Merlin, D; Viennois, E; Xiao, B; Zhang, B; Zhang, Y; Zhang, Z | 1 |
| Chen, S; Cheng, H; Guo, W; Hong, Z; Wang, J; Wu, Z; Yin, Z; Yu, M; Zhao, L; Zhao, Q | 1 |
| Bai, X; Duan, H; Gao, C; Liu, M; Liu, Z; Lü, S; Qin, H; Wei, Y; Wu, X; Zhang, X | 1 |
| Han, SY; Kim, DH; Lee, HS; Ryu, KY | 1 |
| Dalmasso, G; Laroui, H; Merlin, D; Nguyen, HT; Sitaraman, SV; Yan, Y | 1 |
| Crcarevska, MS; Dodov, MG; Gjorgoski, I; Goracinova, K; Petrusevska, G | 1 |
| Bautzová, T; Dvořáčková, K; Gajdziok, J; Lamprecht, A; Pellequer, Y; Rabišková, M; Spilková, J | 1 |
| Glavas Dodov, M; Goracinova, K; Simonoska Crcarevska, M | 1 |
1 review(s) available for glucuronic acid and Colitis
13 other study(ies) available for glucuronic acid and Colitis
| Article | Year |
|---|---|
A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator.
Topics: Amides; Animals; Arachidonic Acids; Calcium; Chemokine CCL8; Colitis; Colon; Dinitrofluorobenzene; Drug Delivery Systems; Endocannabinoids; Ethanolamines; Glucuronic Acid; Glycerides; HaCaT Cells; HEK293 Cells; Humans; Ion Channel Gating; Keratinocytes; Male; Mice, Inbred ICR; Models, Biological; Palmitic Acids; Peroxidase; Poly I-C; TRPV Cation Channels | 2021 |
Synbiotic loaded chitosan-Ca-alginate microparticles reduces inflammation in the TNBS model of rat colitis.
Topics: Alginates; Animals; Chitosan; Colitis; Female; Glucuronic Acid; Hexuronic Acids; Inflammation; Probiotics; Rats; Rats, Wistar; Synbiotics | 2017 |
Pea-protein alginate encapsulation adversely affects development of clinical signs of Citrobacter rodentium-induced colitis in mice treated with probiotics.
Topics: Alginates; Animals; Cecum; Citrobacter rodentium; Colitis; Colon; Disease Models, Animal; Enterobacteriaceae Infections; Female; Glucuronic Acid; Hexuronic Acids; Mice; Mice, Inbred C57BL; Pisum sativum; Plant Proteins; Probiotics | 2018 |
Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease.
Topics: Alginates; Animals; Anti-Inflammatory Agents; Chitosan; Colitis; Colon; Cytokines; Dexamethasone; Dextran Sulfate; Drug Delivery Systems; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Male; Mice, Inbred ICR; Peroxidase; Polymethacrylic Acids | 2018 |
Effect of sodium alginate on dextran sulfate sodium- and 2,4,6-trinitrobenzene sulfonic acid-induced experimental colitis in mice.
Topics: Alginates; Animals; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Glucuronic Acid; Hexuronic Acids; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Peroxidase; Protective Agents; Serum Amyloid A Protein; Trinitrobenzenes | 2013 |
Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.
Topics: Administration, Oral; Alginates; Animals; Cell Line; Chitosan; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Fusion Regulatory Protein-1; Genetic Therapy; Glucuronic Acid; Hexuronic Acids; Homeodomain Proteins; Hydrogels; Interleukin-12; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Knockout; Nanomedicine; Nanoparticles; RNA Interference; RNA, Small Interfering; Severity of Illness Index; Single-Chain Antibodies; Time Factors; Tumor Necrosis Factor-alpha | 2014 |
Targeted delivery of NK007 to macrophages to treat colitis.
Topics: Alginates; Alkaloids; Animals; Anti-Inflammatory Agents; Chemistry, Pharmaceutical; Chitosan; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Indolizines; Macrophages; Mice; Pharmaceutical Preparations; Phenanthrenes | 2015 |
Co-delivery of zinc and 5-aminosalicylic acid from alginate/N-succinyl-chitosan blend microspheres for synergistic therapy of colitis.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chitosan; Colitis; Disease Models, Animal; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Synergism; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Male; Mesalamine; Microscopy, Electron, Scanning; Microspheres; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Zinc | 2017 |
The degradation of glycosaminoglycans by intestinal microflora deteriorates colitis in mice.
Topics: Animals; Anti-Bacterial Agents; Chondroitin Sulfates; Colitis; Galactosamine; Glucosamine; Glucuronic Acid; Glycosaminoglycans; Hyaluronic Acid; Iduronic Acid; Intestinal Mucosa; Male; Mice; Mice, Inbred ICR; Uronic Acids | 2009 |
Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents; Caco-2 Cells; Chemistry, Pharmaceutical; Chitosan; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; Gastrointestinal Agents; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Intestinal Mucosa; Melanocyte-Stimulating Hormones; Mice; Mice, Inbred C57BL; Nanoparticles; Peptide Fragments; Polysaccharides; Solubility; Time Factors | 2010 |
Bioefficacy of budesonide loaded crosslinked polyelectrolyte microparticles in rat model of induced colitis.
Topics: Alginates; Animals; Anti-Inflammatory Agents; Budesonide; Calcium Chloride; Chitosan; Colitis; Cross-Linking Reagents; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Electrolytes; Glucuronic Acid; Hexuronic Acids; Male; Microspheres; Polymethacrylic Acids; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 2009 |
Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents; Buffers; Caffeic Acids; Chemistry, Pharmaceutical; Chitosan; Colitis; Colon; Disease Models, Animal; Drug Compounding; Drug Implants; Drug Stability; Gastrointestinal Agents; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypromellose Derivatives; Male; Methylcellulose; Rats; Rats, Wistar; Rutin; Solubility; Technology, Pharmaceutical; Time Factors; Trinitrobenzenesulfonic Acid; Zinc Acetate | 2012 |
Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa.
Topics: Alginates; Budesonide; Calorimetry; Chitosan; Colitis; Drug Delivery Systems; Drug Stability; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Particle Size; Solubility; Thermogravimetry; X-Ray Diffraction | 2008 |